ABSTRACT
Objectives: To demonstrate the pharmacy infection control services during the mass gathering Hajj period as new initiatives in the Kingdom of Saudi Arabia. Methods: It is a new initiative project drove by national mass gathering pharmaceutical programs. The projects drove the mass gathering medicine guidelines and the international business model, pharmacy project guidelines project management institution guidelines of a new project. The initiative project is written through project management professionals and consisted of several parts, including the initial phase, the planning phase, the execution phase and the monitoring and controlling phase. Results: The mass gathering pharmacy infection control services with a defined vision, mission and goals. The services had various aids, including clinical and economical on pilgrims, as illustrated in the assessment. The continuation was of the project assured by the risk management model description. Besides, the monitoring and controlling of the services as declared. The transition to operation project, though closing the project stage, explored in the analysis. Conclusion: The mass gathering pharmacy infection control services are a new initiative, part of the mass gathering medicine. There are various pharmacy transition care services can be started during the mass gathering with an emphasis on pharmacy personnel, infection control; it is highly suggested to implement in Saudi Arabia.
ABSTRACT
Objective: To explore the pharmaceutical care services during mass gathering (MG) Hajj at the healthcare organizations in Saudi Arabia (SA). Methods: It is a descriptive analysis of a newly established program at the MOH in SA called MG pharmaceutical care program during Hajj and Umra Seasons, which was analyzed within the Pharmacy Strategic Plan 2012-2020 and update the plan with new Saudi vision 2030. Results: MG pharmaceutical care program is a new program established by the healthcare organizations in the last four years, which amongst to provide pharmaceutical care services in various fields. Conclusion: The mass gathering of pharmaceutical care services is a new initiative, part of the mass gathering medicine. The program should expand after the foundation stage with performance indication monitoring and follow up. Further assessment of the new project is required to validate the clinical and economic outcomes to research the high level of quality and professionalism in the future.